Largactilothiazine
Brand names,
Largactilothiazine
Analogs
Largactilothiazine
Brand Names Mixture
Largactilothiazine
Chemical_Formula
C17H20N2S
Largactilothiazine
RX_link
No information avaliable
Largactilothiazine
fda sheet
Largactilothiazine
msds (material safety sheet)
Largactilothiazine
Synthesis Reference
No information avaliable
Largactilothiazine
Molecular Weight
284.42 g/mol
Largactilothiazine
Melting Point
< 25 oC
Largactilothiazine
H2O Solubility
14.2 mg/L
Largactilothiazine
State
Liquid
Largactilothiazine
LogP
4.893
Largactilothiazine
Dosage Forms
Tablet; Oral liquid; Injection
Largactilothiazine
Indication
Used as an adjunct for short term treatment of moderate and severe psychomotor agitation. Also used to treat agitation or restlessness in the elderly.
Largactilothiazine
Pharmacology
Promazine belongs to a group of medications known as the phenothiazine antipsychotics. It acts by blocking a variety of receptors in the brain, particularly dopamine receptors. Dopamine is involved in transmitting signals between brain cells. When there is an excess amount of dopamine in the brain it causes over-stimulation of dopamine receptors. These receptors normally act to modify behaviour and over-stimulation may result in psychotic illness. Promazine hydrochloride blocks these receptors and stops them becoming over-stimulated, thereby helping to control psychotic illness. Promazine has weak extrapyramidal and autonomic side effects which lead to its use in the elderly, for restless or psychotic patients. Its anti-psychotic effect is also weaker and it is not useful in general psychiatry.
Largactilothiazine
Absorption
Absorption may be erratic and peak plasma concentrations show large interindividual differences.
Largactilothiazine
side effects and Toxicity
Side effects include: extrapyramidal symptoms, drowsiness, weight gain, dry mouth, constipation, endocrine effects (such as gynaecomastia and menstrual disturbance), sensitivity to sunlight and haemolytic anaemia.
Largactilothiazine
Patient Information
No information avaliable
Largactilothiazine
Organisms Affected
Humans and other mammals